The idea that your intestines could influence your mood, your memory, and your risk of Alzheimer’s sounds bizarre. The science says it’s not only possible — it’s one of the most important biological connections in your entire body.
The second brain you didn’t know you had
Your gut contains approximately 500 million neurons — more than the spinal cord — organized into a network called the enteric nervous system (ENS). This system is so extensive and so functionally independent that neuroscientists have nicknamed it the ‘second brain.’ It can regulate digestion completely autonomously, without input from the central nervous system. But it doesn’t operate in isolation. It is in constant, bidirectional communication with the brain above it — through the vagus nerve, through the bloodstream, and through the microbial communities that populate the gut.
This entire system — the microbiota, the gut, and the brain — is now understood as an integrated axis: the microbiota-gut-brain axis (MGBA). A landmark review published in Frontiers in Neuroanatomy (February 2025) by researchers from the UAE University confirmed that the MGBA serves as a conduit between the central nervous system (CNS) and the enteric nervous system (ENS), facilitating communication between the emotional and cognitive centers of the brain via diverse pathways.
How gut bacteria influence your brain biology
The gut microbiome — the roughly 38 trillion bacteria, viruses, and fungi that inhabit your intestines — produces or modulates a staggering array of compounds that directly influence brain function. Gut bacteria produce around 90% of the body’s serotonin — yes, the neurotransmitter most associated with mood and depression is primarily manufactured in your intestines, not your brain. They produce short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate, which cross the blood-brain barrier, modulate microglia function, and affect neuroplasticity.
The 2025 UAE University review confirms that SCFAs play a pivotal role in the MGBA: they can modify the blood-brain barrier’s permeability, influence microglia structure and reactivity, and affect neuronal and astrocyte function. Disruptions to normal SCFA production — caused by antibiotic use, poor diet, or stress — have been linked to changes in anxiety, cognitive flexibility, and even the rate of neurodegeneration in conditions like Alzheimer’s and Parkinson’s disease.
🔬 Gut-brain findings from 2025: The npnHub 2025 neuroscience roundup highlighted gut-brain axis findings as one of the top 10 breakthroughs of the year — specifically, that gut microbiota composition is linked to mood and cognitive flexibility. Changes in the microbiome can precede changes in mood and cognitive function by days to weeks, suggesting the microbiome may be an early warning system for neurological change.
The vagus nerve: the highway between gut and brain
The primary physical channel connecting gut to brain is the vagus nerve — the longest cranial nerve in the body, running from the brainstem all the way down to the abdomen. About 80-90% of the fibers in the vagus nerve carry information upward, from gut to brain — making it far more of a sensory reporting line than a command channel. The brain receives a constant stream of information about gut state, microbial activity, and intestinal inflammation through this pathway.
Vagus nerve stimulation (VNS) — artificially activating this nerve — is already an approved treatment for depression and epilepsy, and is being studied for inflammatory conditions, Alzheimer’s, and post-traumatic stress disorder. The mechanism connects directly to the gut-brain axis: stimulating the vagus nerve modulates the brain’s immune response, reduces neuroinflammation, and affects the activity of the amygdala and hippocampus — the same structures central to emotion and memory.
Gut microbiome and Alzheimer’s disease
The connection between the gut microbiome and Alzheimer’s disease is one of the most actively investigated areas in neuroscience. The UAE University 2025 review specifically discusses how short-chain fatty acids produced by gut bacteria influence the progression of Alzheimer’s disease through their effects on microglia, neuroinflammation, and the blood-brain barrier.
Patients with Alzheimer’s consistently show significantly different gut microbiome compositions compared to healthy age-matched controls — with reduced diversity and altered proportions of key microbial groups. Whether this dysbiosis is a cause or a consequence of neurodegeneration, or a bit of both in a mutually reinforcing feedback loop, is still being worked out. But the connection is consistent enough that the microbiome is now being seriously considered as both a diagnostic marker and a therapeutic target for neurodegenerative disease.
💡 Practical implication: The gut-brain axis provides a biological rationale for why diet, sleep, stress management, and probiotic interventions can measurably affect mood, cognition, and brain health — not through some vague ‘wellness’ mechanism, but through specific, documented pathways: SCFA production, vagus nerve signaling, neuroinflammation modulation, and neurotransmitter synthesis.